# Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction

> **NCT02491008** · PHASE4 · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 145 (actual)

## Conditions studied

- Thyroid Dysfunction
- Bone Mineral Density
- Osteoporosis
- Fractures, Bone

## Interventions

- **DRUG:** Levothyroxine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02491008
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 145 (ACTUAL)
- **Last updated:** 2017-02-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02491008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02491008, "Novel Biomarkers and Skeletal Outcomes Associated With Subclinical Thyroid Dysfunction". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02491008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*